In the same way, 22q13 duplications involving SHANK3 were reported in patients with Asperger syndrome, attention deficit-hyperactivity disorder (ADHD) or schizophrenia, suggesting that an overexpression of this gene could be also pathogenic [27]. This evidence concerns the gene SHANK3 and attention deficit-hyperactivity disorder.